DK0630248T3 - Anvendelse af estriol til fremstilling af et transdermalt terapeutisk system til behandling af klimakteriel osteoporosis - Google Patents

Anvendelse af estriol til fremstilling af et transdermalt terapeutisk system til behandling af klimakteriel osteoporosis

Info

Publication number: DK0630248T3
Authority: DK; Denmark
Prior art keywords: estriol; treatment; pct; preparation; therapeutic system
Prior art date: 1992-03-21

Application number

DK93920566T

Other languages

English (en)

Inventor

Walter Elger

Birgitt Schneider

Michael Oettel

Michael Ernst

Bler Doris H

Michael Dittgen

Original Assignee

Entec

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-03-21

Filing date

1993-03-18

Publication date

1999-06-23

1993-03-18 Application filed by Entec filed Critical Entec

1999-06-23 Application granted granted Critical

1999-06-23 Publication of DK0630248T3 publication Critical patent/DK0630248T3/da

Links

PROQIPRRNZUXQM-UHFFFAOYSA-N (16alpha,17betaOH)-Estra-1,3,5(10)-triene-3,16,17-triol Natural products OC1=CC=C2C3CCC(C)(C(C(O)C4)O)C4C3CCC2=C1 PROQIPRRNZUXQM-UHFFFAOYSA-N 0.000 title abstract 3
208000001132 Osteoporosis Diseases 0.000 title abstract 3
PROQIPRRNZUXQM-ZXXIGWHRSA-N estriol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)C4)O)[C@@H]4[C@@H]3CCC2=C1 PROQIPRRNZUXQM-ZXXIGWHRSA-N 0.000 title abstract 3
229960001348 estriol Drugs 0.000 title abstract 3
230000001225 therapeutic effect Effects 0.000 title 1
239000004480 active ingredient Substances 0.000 abstract 2
230000003262 anti-osteoporosis Effects 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Physical Education & Sports Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Nutrition Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Steroid Compounds (AREA)

DK93920566T 1992-03-21 1993-03-18 Anvendelse af estriol til fremstilling af et transdermalt terapeutisk system til behandling af klimakteriel osteoporosis DK0630248T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE4209295		1992-03-21
PCT/EP1993/000636 WO1993018774A1 (de)	1992-03-21	1993-03-18	Verwendung von östriol zur behandlung von klimakterischer osteoporose

Publications (1)

Publication Number	Publication Date
DK0630248T3 true DK0630248T3 (da)	1999-06-23

Family

ID=6454737

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK93920566T DK0630248T3 (da)	1992-03-21	1993-03-18	Anvendelse af estriol til fremstilling af et transdermalt terapeutisk system til behandling af klimakteriel osteoporosis

Country Status (12)

Country	Link
US (1)	US5614213A (da)
EP (1)	EP0630248B1 (da)
JP (1)	JPH07504672A (da)
AT (1)	ATE172118T1 (da)
AU (1)	AU665997B2 (da)
CA (1)	CA2131822C (da)
DE (1)	DE59309063D1 (da)
DK (1)	DK0630248T3 (da)
ES (1)	ES2123666T3 (da)
HU (1)	HU218290B (da)
RU (1)	RU2119337C1 (da)
WO (1)	WO1993018774A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19635883A1 (de) *	1996-09-04	1998-03-05	Lohmann Therapie Syst Lts	Transdermales therapeutisches System mit einer Östriol enthaltenden Wirkstoffkombination
DE19918644A1 (de) *	1999-04-16	2000-10-26	Jenapharm Gmbh	Pharmazeutische Zusammensetzungen zur lokalen, intradermalen Applikation von Estrogenen
DE102004023984A1 (de) *	2004-05-14	2005-12-08	Hf Arzneimittelforschung Gmbh	Filmförmiges, oral zu verabreichendes Arzneimittel, enthaltend Estriol
RU2440155C1 (ru) *	2010-07-20	2012-01-20	Наталья Александровна Гладкова	Способ лечения климактерического синдрома
EP3395336A1 (en)	2017-04-28	2018-10-31	Nitto Denko Corporation	Transdermal absorption preparation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3510555A1 (de) *	1985-03-21	1986-09-25	Schering AG, 1000 Berlin und 4709 Bergkamen	Estriolester
IE61236B1 (en) *	1986-07-15	1994-10-19	American Home Prod	Combination dosage form for pre-menopausal women
EP0300523B1 (en) *	1987-07-06	1991-08-14	Akzo N.V.	Pharmaceutical dosage unit for the prevention or treatment of climacteric complaints
US5108995A (en) *	1987-09-24	1992-04-28	Jencap Research Ltd.	Hormone preparation and method
DE3910578A1 (de) *	1989-03-29	1990-10-04	Schering Ag	Mittel zur transdermalen applikation enthaltend gestoden
EP0394429B1 (de) *	1988-10-27	1996-01-10	Schering Aktiengesellschaft	Mittel zur transdermalen applikation enthaltend gestoden
US5116828A (en) *	1989-10-26	1992-05-26	Nippon Zoki Pharmaceutical Co., Ltd.	Pharmaceutical composition for treatment of osteoporosis
DE69201725T2 (de) *	1991-02-26	1996-04-18	Procter & Gamble Pharmaceuticals, Inc. (An Ohio Corp.), Norwich, N.Y.	Behandlungsmethoden für osteoporose.

1993
- 1993-03-18 DE DE59309063T patent/DE59309063D1/de not_active Expired - Lifetime
- 1993-03-18 US US08/295,723 patent/US5614213A/en not_active Expired - Lifetime
- 1993-03-18 AT AT93920566T patent/ATE172118T1/de not_active IP Right Cessation
- 1993-03-18 ES ES93920566T patent/ES2123666T3/es not_active Expired - Lifetime
- 1993-03-18 EP EP93920566A patent/EP0630248B1/de not_active Expired - Lifetime
- 1993-03-18 DK DK93920566T patent/DK0630248T3/da active
- 1993-03-18 HU HU9402698A patent/HU218290B/hu not_active IP Right Cessation
- 1993-03-18 JP JP5516265A patent/JPH07504672A/ja active Pending
- 1993-03-18 WO PCT/EP1993/000636 patent/WO1993018774A1/de not_active Ceased
- 1993-03-18 RU RU94045856A patent/RU2119337C1/ru active
- 1993-03-18 CA CA002131822A patent/CA2131822C/en not_active Expired - Fee Related
- 1993-03-18 AU AU37500/93A patent/AU665997B2/en not_active Ceased

Also Published As

Publication number	Publication date
WO1993018774A1 (de)	1993-09-30
RU94045856A (ru)	1996-08-20
JPH07504672A (ja)	1995-05-25
RU2119337C1 (ru)	1998-09-27
HU218290B (en)	2000-07-28
DE59309063D1 (de)	1998-11-19
AU665997B2 (en)	1996-01-25
CA2131822C (en)	2002-12-17
HUT68213A (en)	1995-06-28
ES2123666T3 (es)	1999-01-16
HU9402698D0 (en)	1994-11-28
US5614213A (en)	1997-03-25
EP0630248A1 (de)	1994-12-28
ATE172118T1 (de)	1998-10-15
EP0630248B1 (de)	1998-10-14
AU3750093A (en)	1993-10-21
CA2131822A1 (en)	1993-09-22

Similar Documents

Publication	Publication Date	Title
ATE162725T1 (de)	1998-02-15	Verbesserte hautpenetrationssysteme fuer erhoehte topische freisetzung von arzneimitteln
UA26213C2 (uk)	1999-07-19	Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
NO962162D0 (no)	1996-05-28	Dipeptider som bevirker frigjöring av veksthormon
ATE220896T1 (de)	2002-08-15	Hydrogelformulierung mit gesteuerter freisetzung
MY129175A (en)	2007-03-30	Sertraline salts and sustained-release dosage forms of sertraline
AU4529596A (en)	1996-07-24	Pharmaceutical compositions for prevention and treatment of ulcerative colitis
DE60239343D1 (de)	2011-04-14	Mittel zur behandlung von erkrankungen, die mit knochenschwund einhergehen, mit ep4-agonist als wirkstoff
PT1011632E (pt)	2004-03-31	Composicao farmaceutica para o tratamento de dismenorreia e parto prematuro
DE69825603D1 (de)	2004-09-16	2,3,5-trisubstituierte pyridine als inhibitoren von cyclooxygenase-2
ES2098920T3 (es)	1997-05-01	Formulaciones farmaceuticas para el tratamiento de la dependencia a la nicotina.
ATE232874T1 (de)	2003-03-15	Prostaglandin-konjugate zur behandlung von knochenkrankheiten
ATE171873T1 (de)	1998-10-15	Antiglucocorticoidsteroide zur behandlung von angststörungen
DK0679393T3 (da)	1998-09-14	Pharmaceutisk præparat til behandling af osteoporose indeholdende xanthohumol
DE69535131D1 (de)	2006-09-07	Pharmazeutische zusammensetzungen zur vorbeugung und behandlung von störungen des zentralnervensystems
DE69838882D1 (de)	2008-01-31	Pharmazeutisch wirksame verbindungen und methoden zu ihrer anwendung
WO2004058235A3 (en)	2005-02-24	Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin d derivative
DK0630248T3 (da)	1999-06-23	Anvendelse af estriol til fremstilling af et transdermalt terapeutisk system til behandling af klimakteriel osteoporosis
DK0825865T3 (da)	2002-02-18	Transdermalt, terapeutisk system for administrering af testosteron eller testosteronderivat
BR9608392A (pt)	1999-11-30	Preparação multiparticulada de liberação controlada e forma de dosagem em tablete.
DK0996435T3 (da)	2003-01-27	Aminosyrederivater anvendelige til behandling af slagtilfælde
DK0762883T3 (da)	2002-03-11	Pyridylbisphosphonater til anvendelse som terapeutisk middel
DK0665830T3 (da)	1997-09-01	Tilidin-dihydrogenorthophosphat, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende det.
ATA57894A (de)	2000-09-15	Mittel zur behandlung von osteoporose
ECSP972347A (es)	1998-12-14	Prevencion de la perdida y restauracion de la masa osea por determinados agonistas de prostaglandinas